In vivo CT imaging of gold nanoparticle-labeled exosomes in a myocardial infarction mouse model

Lianggeng Gong,Yingying Weng,Wei Zhou,Kunchi Zhang,Wei Li,Jia Jiang,Jun Zhu
DOI: https://doi.org/10.21037/atm-21-981
IF: 3.616
2021-03-01
Annals of Translational Medicine
Abstract:BACKGROUND: Acute myocardial infarction (MI) is the primary factor leading to cardiovascular diseases, which are the main causes of morbidity and mortality in developed countries. Mesenchymal stem cell (MSC)-derived exosomes have been reported to improve heart function after MI; however, the molecular mechanisms responsible for this are unknown. <i>In vivo</i> imaging can reveal the trafficking process and <i>in vivo</i> biodistribution of exosomes, which may provide an insight into the communication mechanisms and pharmacokinetics of exosomes.METHODS: Glucose modified gold nanoparticles were used to label MSC-derived exosomes, aimed at minimizing membrane damage and maintaining the integrity of the exosomes. After labeling, the exosomes were visualized by <i>in vivo</i> computed tomography (CT) imaging to determine the biodistribution at 4 and 24 h after injection into a MI mouse model.RESULTS: MSC-derived exosomes were successfully labeled by glucose modified gold nanoparticles and CT imaging of these labeled exosomes indicated that MSC-Exo remained in the MI area for up to 24 h after intramyocardial injection. Additionally, few MSC-Exo were observed in some other organs, particularly the liver, spleen, and kidney.CONCLUSIONS: A gentle method was used for loading GNPs into exosomes, and their successful labeling without causing aggregation was verified. <i>In vivo</i> CT imaging revealed the retention of MSC-Exo in the MI area, indicating their usefulness for improving heart function after infarction.
oncology,medicine, research & experimental
What problem does this paper attempt to address?